
Differential Bio offers a Virtual Scale-up Platform that leverages robotic lab automation and AI-driven insights to make microbial growth predictable, scalable, and cost-effective. Their process involves automated experiments for data acquisition, digital modeling using specialized AI models for accurate predictions from wet-lab data, and bioprocess optimization delivered through an online platform. This approach aims to reduce R&D costs by up to 3x, optimize bioprocesses in as little as 4 weeks, and achieve up to an 80% titer improvement. They cater to various applications within biomanufacturing, including medium optimization, strain selection, and downstream processing optimization, ultimately accelerating time to market and enhancing the efficiency and sustainability of bioprocesses.

Differential Bio offers a Virtual Scale-up Platform that leverages robotic lab automation and AI-driven insights to make microbial growth predictable, scalable, and cost-effective. Their process involves automated experiments for data acquisition, digital modeling using specialized AI models for accurate predictions from wet-lab data, and bioprocess optimization delivered through an online platform. This approach aims to reduce R&D costs by up to 3x, optimize bioprocesses in as little as 4 weeks, and achieve up to an 80% titer improvement. They cater to various applications within biomanufacturing, including medium optimization, strain selection, and downstream processing optimization, ultimately accelerating time to market and enhancing the efficiency and sustainability of bioprocesses.
What they do: Virtual Scale-up Platform combining robotic microliter fermentation, high-throughput data and AI models to optimize microbial bioprocess scale-up
Founded: 2023
Headquarters / registration: Feldkirchen (near Munich), registered as Differential Bio GmbH, HRB 289360
Recent funding: €2M pre-seed announced March 26, 2025
Founding team: Christian Spier (CEO), Dong Zhao (CSO), Martin Patz (CTO); Konstantin Amm (Founder's Associate)
Bioprocess scale-up and optimization for microbial fermentation in industrial biomanufacturing.
2023
Biotechnology
€2,000,000
Round included participation from Carbon13, Climate Capital, Better Ventures, CDTM Venture Fund and angel investors
“Led by impact- and climate-focused investors (Ananda Impact Ventures, ReGen Ventures) with participation from climate/impact funds”
| Company |
|---|